MEDIFAST INC

NYSE:MED USA Personal Services
Market Cap
$110.46 Million
Market Cap Rank
#18595 Global
#6905 in USA
Share Price
$10.05
Change (1 day)
+0.00%
52-Week Range
$9.53 - $15.22
All Time High
$294.26
About

Medifast, Inc., through its subsidiaries, operates as a health and wellness company that provides habit-based and coach-guided lifestyle solutions to address obesity and support a healthy life in the United States. The company offers weight loss and weight management plans; and GLP-1 support plans that provide access to GLP-1 medications where clinically appropriate under the OPTAVIA brand name. … Read more

MEDIFAST INC (MED) - Net Assets

Latest net assets as of September 2025: $214.71 Million USD

Based on the latest financial reports, MEDIFAST INC (MED) has net assets worth $214.71 Million USD as of September 2025.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($268.21 Million) and total liabilities ($53.50 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets $214.71 Million
% of Total Assets 80.05%
Annual Growth Rate 13.84%
5-Year Change 33.62%
10-Year Change 137.19%
Growth Volatility 55.74

MEDIFAST INC - Net Assets Trend (1996–2024)

This chart illustrates how MEDIFAST INC's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for MEDIFAST INC (1996–2024)

The table below shows the annual net assets of MEDIFAST INC from 1996 to 2024.

Year Net Assets Change
2024-12-31 $210.11 Million +4.28%
2023-12-31 $201.48 Million +29.95%
2022-12-31 $155.04 Million -23.43%
2021-12-31 $202.47 Million +28.76%
2020-12-31 $157.25 Million +50.00%
2019-12-31 $104.83 Million -3.92%
2018-12-31 $109.11 Million +0.48%
2017-12-31 $108.58 Million +13.09%
2016-12-31 $96.02 Million +8.39%
2015-12-31 $88.58 Million +10.08%
2014-12-31 $80.48 Million -18.23%
2013-12-31 $98.42 Million +8.40%
2012-12-31 $90.79 Million +23.68%
2011-12-31 $73.40 Million +2.01%
2010-12-31 $71.96 Million +35.94%
2009-12-31 $52.93 Million +38.66%
2008-12-31 $38.17 Million +17.75%
2007-12-31 $32.42 Million +15.10%
2006-12-31 $28.17 Million +27.91%
2005-12-31 $22.02 Million +14.66%
2004-12-31 $19.21 Million +12.47%
2003-12-31 $17.08 Million +206.15%
2002-12-31 $5.58 Million +119.78%
2001-12-31 $2.54 Million +109.75%
2000-12-31 $1.21 Million +668.08%
1999-12-31 $-213.00K -109.92%
1998-12-31 $2.15 Million +6.50%
1997-12-31 $2.02 Million -63.83%
1996-12-31 $5.57 Million --

Equity Component Analysis

This analysis shows how different components contribute to MEDIFAST INC's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have grown by 17814600000.0% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2024)

Component Amount Percentage
Retained Earnings $176.78 Million 84.14%
Common Stock $11.00K 0.01%
Other Comprehensive Income $180.00K 0.09%
Other Components $33.14 Million 15.77%
Total Equity $210.11 Million 100.00%

MEDIFAST INC Competitors by Market Cap

The table below lists competitors of MEDIFAST INC ranked by their market capitalization.

Equity Growth Attribution

This analysis shows how different factors contributed to changes in MEDIFAST INC's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2023 to 2024, total equity changed from 201,481,000 to 210,109,000, a change of 8,628,000 (4.3%).
  • Net income of 2,091,000 contributed positively to equity growth.
  • Dividend payments of 715,000 reduced retained earnings.
  • Share repurchases of 836,000 reduced equity.
  • Other comprehensive income decreased equity by 68,000.
  • Other factors increased equity by 8,156,000.

Equity Change Factors (2023 to 2024)

Factor Impact Contribution
Net Income $2.09 Million +1.0%
Dividends Paid $715.00K -0.34%
Share Repurchases $836.00K -0.4%
Other Comprehensive Income $-68.00K -0.03%
Other Changes $8.16 Million +3.88%
Total Change $- 4.28%

Book Value vs Market Value Analysis

This analysis compares MEDIFAST INC's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 0.52x
  • The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
  • The price-to-book ratio has decreased from 7.78x to 0.52x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
1996-12-31 $1.29 $10.05 x
1997-12-31 $0.47 $10.05 x
1998-12-31 $0.45 $10.05 x
1999-12-31 $-0.04 $10.05 x
2000-12-31 $0.16 $10.05 x
2001-12-31 $0.31 $10.05 x
2002-12-31 $0.64 $10.05 x
2003-12-31 $1.56 $10.05 x
2004-12-31 $1.55 $10.05 x
2005-12-31 $1.72 $10.05 x
2006-12-31 $2.09 $10.05 x
2007-12-31 $2.38 $10.05 x
2008-12-31 $2.66 $10.05 x
2009-12-31 $3.59 $10.05 x
2010-12-31 $4.94 $10.05 x
2011-12-31 $5.17 $10.05 x
2012-12-31 $6.61 $10.05 x
2013-12-31 $7.12 $10.05 x
2014-12-31 $6.30 $10.05 x
2015-12-31 $7.34 $10.05 x
2016-12-31 $8.04 $10.05 x
2017-12-31 $8.98 $10.05 x
2018-12-31 $9.03 $10.05 x
2019-12-31 $8.65 $10.05 x
2020-12-31 $13.27 $10.05 x
2021-12-31 $17.14 $10.05 x
2022-12-31 $13.75 $10.05 x
2023-12-31 $18.45 $10.05 x
2024-12-31 $19.17 $10.05 x

Capital Efficiency Dashboard

This dashboard shows how efficiently MEDIFAST INC utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 1.00%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 0.35%
  • • Asset Turnover: 2.12x
  • • Equity Multiplier: 1.35x
  • Recent ROE (1.00%) is below the historical average (21.50%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
1996 5.74% 1.94% 1.44x 2.05x $-237.40K
1997 -183.38% -25.74% 2.07x 3.44x $-3.90 Million
1998 -44.20% -5.97% 1.54x 4.82x $-1.16 Million
1999 0.00% -68.63% 2.20x 0.00x $-3.17 Million
2000 107.69% 33.43% 1.25x 2.58x $1.18 Million
2001 23.17% 11.71% 1.50x 1.32x $334.20K
2002 47.02% 21.25% 1.25x 1.77x $2.07 Million
2003 14.11% 9.50% 1.05x 1.42x $702.30K
2004 9.10% 6.39% 1.05x 1.35x $-173.60K
2005 12.38% 6.80% 1.31x 1.39x $524.90K
2006 18.04% 6.86% 2.01x 1.31x $2.27 Million
2007 11.84% 4.58% 1.92x 1.35x $595.00K
2008 14.24% 5.15% 2.07x 1.34x $1.62 Million
2009 22.60% 7.22% 2.58x 1.21x $6.67 Million
2010 0.03% 7.61% 0.00x 1.31x $-7.18 Million
2011 25.26% 6.22% 2.82x 1.44x $11.20 Million
2012 17.49% 4.45% 2.74x 1.43x $6.80 Million
2013 24.35% 6.72% 2.69x 1.35x $14.13 Million
2014 16.38% 4.62% 2.46x 1.44x $5.13 Million
2015 22.64% 7.35% 2.32x 1.32x $11.20 Million
2016 18.58% 6.50% 2.26x 1.26x $8.23 Million
2017 25.53% 9.19% 2.07x 1.34x $16.86 Million
2018 51.13% 11.14% 2.96x 1.55x $44.88 Million
2019 74.32% 10.92% 3.67x 1.86x $67.43 Million
2020 65.41% 11.00% 3.39x 1.76x $87.13 Million
2021 81.01% 10.75% 3.83x 1.97x $143.78 Million
2022 92.60% 8.98% 5.06x 2.04x $128.06 Million
2023 49.34% 9.27% 3.46x 1.54x $79.27 Million
2024 1.00% 0.35% 2.12x 1.35x $-18.92 Million

Industry Comparison

This section compares MEDIFAST INC's net assets metrics with peer companies in the Personal Services industry.

Industry Context

  • Industry: Personal Services
  • Average net assets among peers: $306,169,570
  • Average return on equity (ROE) among peers: 458.77%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
MEDIFAST INC (MED) $214.71 Million 5.74% 0.25x $92.13 Million
Andersen Group Inc. (ANDG) $177.50 Million 66.86% 1.08x $242.88K
Bright Horizons Family Solutions Inc (BFAM) $145.51 Million 13.75% 0.70x $4.17 Billion
Click Holdings Limited (CLIK) $403.31K 199.02% 3.08x $871.85K
Carriage Services Inc (CSV) $202.10 Million 4.70% 1.31x $653.20 Million
CVS Group plc (CVSGF) $257.00 Million 16.30% 1.23x $947.94 Million
Dror Ortho-Design Inc. (DROR) $-374.60K 0.00% 0.00x $4.09 Million
E-Home Household Service Holdings Ltd (EJH) $64.27 Million 9.97% 0.16x $2.03 Million
Eventiko Inc (EVTK) $-14.26K 0.00% 0.00x $3.58 Million
Fu Shou Yuan International Group Limited (FSHUF) $2.21 Billion 10.41% 0.33x $717.28 Million
Frontdoor Inc (FTDR) $3.00 Million 4266.67% 355.33x $4.51 Billion